Premier Health of America Inc.
PHA.VTSXVHealthcare● Active
$0.02
+$0.00(+0.00%)
Market Cap$1110283
P/E Ratio—
52W High$0.07
52W Low$0.01
Premier Health of America Inc. (PHA.V) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PHA.V · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 26, 2026EPS Actual
-$0.05
Revenue
$0.02B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 26, 2026
After Market Close
PHA.V reports quarterly as a TSXV-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 20, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2026 | Jun 8, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Feb 26, 2026 | — | -$0.05 | — | $0.02B | — | — |
| ▼ Q1 FY2026 | Jan 27, 2026 | $0.02 | -$0.12 | -700.0% | $0.02B | $0.05B | -53.9% |
| ▼ Q3 FY2025 | Aug 19, 2025 | $0.02 | -$0.06 | -418.1% | $0.02B | $0.04B | -50.8% |
| ▼ Q2 FY2025 | May 21, 2025 | $0.02 | -$0.06 | -383.8% | $0.03B | $0.04B | -38.2% |
| ▼ Q1 FY2025 | Feb 24, 2025 | $0.01 | -$0.04 | -507.3% | $0.03B | $0.04B | -25.8% |
| ▼ Q4 FY2024 | Dec 10, 2024 | $0.01 | -$0.04 | -500.0% | $0.03B | $0.04B | -21.6% |
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 8, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 26, 2026
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q1 FY2026
Jan 27, 2026Miss
EPS Actual
-$0.12
EPS Est.
$0.02
EPS Surpr.
-700.0%
Revenue
$0.02B
Q3 FY2025
Aug 19, 2025Miss
EPS Actual
-$0.06
EPS Est.
$0.02
EPS Surpr.
-418.1%
Revenue
$0.02B
Q2 FY2025
May 21, 2025Miss
EPS Actual
-$0.06
EPS Est.
$0.02
EPS Surpr.
-383.8%
Revenue
$0.03B
Q1 FY2025
Feb 24, 2025Miss
EPS Actual
-$0.04
EPS Est.
$0.01
EPS Surpr.
-507.3%
Revenue
$0.03B
Q4 FY2024
Dec 10, 2024Miss
EPS Actual
-$0.04
EPS Est.
$0.01
EPS Surpr.
-500.0%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.02 | $0.02 | $0.02 | 1 |
| Q2 FY2025 | $0.02 | $0.02 | $0.02 | 1 |
| Q1 FY2025 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2024 | $0.01 | $0.01 | $0.01 | 1 |
| Q3 FY2024 | $0.01 | $0.01 | $0.01 | 1 |
| Q2 FY2024 | $0.01 | $0.01 | $0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 26, 2026 | — | $0.02 | $0.02 | +0.00% |
| ▼ Q1 FY2026 | Jan 27, 2026 | -700.0% | $0.03 | $0.03 | -16.67% |
| ▼ Q3 FY2025 | Aug 19, 2025 | -418.1% | $0.04 | $0.04 | +14.29% |
| ▼ Q2 FY2025 | May 21, 2025 | -383.8% | $0.09 | $0.09 | -5.56% |
| ▼ Q1 FY2025 | Feb 24, 2025 | -507.3% | $0.18 | $0.18 | +0.00% |
| ▼ Q4 FY2024 | Dec 10, 2024 | -500.0% | $0.14 | $0.14 | +0.00% |
| — Q3 FY2024 | Aug 21, 2024 | — | $0.37 | $0.37 | -1.35% |
| — Q2 FY2024 | May 23, 2024 | — | $0.40 | $0.40 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 26, 2026
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q1 FY2026-16.67%
Report Date
Jan 27, 2026
EPS Beat/Miss
-700.0%
Price Before
$0.03
Price After
$0.03
Q3 FY2025+14.29%
Report Date
Aug 19, 2025
EPS Beat/Miss
-418.1%
Price Before
$0.04
Price After
$0.04
Q2 FY2025-5.56%
Report Date
May 21, 2025
EPS Beat/Miss
-383.8%
Price Before
$0.09
Price After
$0.09
Q1 FY2025+0.00%
Report Date
Feb 24, 2025
EPS Beat/Miss
-507.3%
Price Before
$0.18
Price After
$0.18
Q4 FY2024+0.00%
Report Date
Dec 10, 2024
EPS Beat/Miss
-500.0%
Price Before
$0.14
Price After
$0.14
Q3 FY2024-1.35%
Report Date
Aug 21, 2024
EPS Beat/Miss
—
Price Before
$0.37
Price After
$0.37
Q2 FY2024+0.00%
Report Date
May 23, 2024
EPS Beat/Miss
—
Price Before
$0.40
Price After
$0.40
Avg Miss Reaction-1.59%
Beat Rate0 / 8 quarters
Largest Move-16.67% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PHA.V ends December
Premier Health of America Inc. (PHA.V) most recently reported earnings on February 26, 2026 for Q1 FY2026, posting EPS of $-0.05 (in line with the analyst consensus of —). The next PHA.V earnings date is expected around September 1, 2026.
Each quarter, investors track PHA.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PHA.V revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PHA.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PHA.V earnings · 4 questionsPremier Health of America Inc.'s next earnings report is expected around September 1, 2026. PHA.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PHA.V historically reports after market close (AMC).
PHA.V earnings datewhen is PHA.V earningsPHA.V next earnings datewhen does PHA.V report earningsPHA.V earnings calendar
▸ Source: FMP · Premier Health of America Inc. SEC filings · US GAAP · Premier Health of America Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026